| Date Filed | Type | Description |
| 01/03/2023 |
SC 13G/A
| TISCH THOMAS J reports a 5.2% stake in Seritage Growth Properties |
| 01/03/2023 |
SC 13G/A
| TISCH THOMAS J reports a 6.4% stake in Lands’ End, Inc. |
| 01/03/2022 |
SC 13G/A
| TISCH THOMAS J reports a 6.7% stake in Seritage Growth Properties |
| 03/18/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/12/2021 |
SC 13G
| TISCH THOMAS J reports a 6.1% stake in Lands’ End, Inc. |
| 03/22/2018 |
4
| TISCH THOMAS J (Director) has filed a Form 4 on SEARS HOLDINGS CORP|
Txns:
| Granted options to buy
@ $8.33, valued at
$0
Granted options to buy
@ $8.33, valued at
$0 |
|
| 01/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/23/2015 |
4
| TISCH THOMAS J (Director) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Disposed/sold 373,560 shares
@ $0
Disposed/sold 378,435 shares
@ $0
Disposed/sold 7,500 options to buy
@ $40.32, valued at
$302.4k
Disposed/sold 15,000 options to buy
@ $40.74, valued at
$611.1k
Disposed/sold 7,500 options to buy
@ $80.35, valued at
$602.6k
|
|
| 11/25/2014 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
| 11/20/2014 |
4
| TISCH THOMAS J (Director) has filed a Form 4 on SEARS HOLDINGS CORP|
Txns:
| Exercised 7,287 rights
@ $500, valued at
$3.6M
Exercised 128,246 warrants
@ $28.41, valued at
$3.6M
Exercised 10,956 options to buy
@ $500, valued at
$5.5M
Exercised 192,819 options to buy
@ $28.41, valued at
$5.5M
|
|
| 06/05/2014 |
4
| TISCH THOMAS J (Director) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Granted 7,500 options to buy
@ $80.35, valued at
$602.6k
|
|
| 04/17/2014 |
4
| TISCH THOMAS J (Director) has filed a Form 4 on SEARS HOLDINGS CORP|
Txns:
| Bought 375,000 shares
@ $33.6, valued at
$12.6M
Bought 100,000 shares
@ $33.4, valued at
$3.3M
|
|
| 06/10/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/15/2013 |
4
| TISCH THOMAS J (Director) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Bought 21,039 shares
@ $47.53, valued at
$1000k
|
|
| 07/13/2012 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/13/2012 |
4
| TISCH THOMAS J (Director) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Bought 36,500 shares
@ $41.2, valued at
$1.5M
Bought 36,500 shares
@ $41.2, valued at
$1.5M
|
|
| 06/29/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/17/2012 |
4/A
| TISCH THOMAS J (10% Owner) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Bought 120,000 shares
@ $25.18, valued at
$3M
|
|
| 11/08/2011 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership |
| 11/08/2011 |
3
| TISCH THOMAS J (10% Owner) has filed a Form 3 on SYNAGEVA BIOPHARMA CORP |
| 02/16/2010 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 02/16/2010 |
SC 13G/A
| TISCH THOMAS J reports a 0% stake in NEUROGEN CORPORATION |
| 01/30/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |